SCHEMBL6599676

SCHEMBL6599676

COCc1cccc(C=CCO)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 1/20 0.50
CYP4A11 Q02928 1/20 0.50
ALDH1A1 P00352 2/20 0.43
CYP3A4 P08684 1/20 0.43
RECQL P46063 1/20 0.43
KDM1A O60341 1/20 0.41
IDO1 P14902 4/20 0.40
KDM4E B2RXH2 1/20 0.39
PKM P14618 1/20 0.39
ABL1 P00519 1/20 0.39
BCR P11274 1/20 0.39
ERN1 O75460 1/20 0.38
LCK P06239 1/20 0.38
AGXT P21549 2/20 0.38
ALOX5 P09917 1/20 0.38
RHOA P61586 1/20 0.37
MAOA P21397 1/20 0.37
MAOB P27338 1/20 0.37
CHRM2 P08172 1/20 0.36
CHRM1 P11229 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6599668 1.00 CYP4F2 (0.50) CYP4F2CYP4A11ALDH1A1CYP3A4RECQL
SCHEMBL6601394 0.83 CYP4F2 (0.47) CYP4F2CYP4A11ALDH1A1KDM1AIDO1
SCHEMBL6601391 0.83 CYP4F2 (0.47) CYP4F2CYP4A11ALDH1A1KDM1AIDO1
SCHEMBL2095088 0.81 LCK (0.53) ALDH1A1CYP3A4KDM4EPKMLCK
SCHEMBL10858214 0.81 ALDH1A1 (0.47) CYP4F2CYP4A11ALDH1A1CYP3A4RECQL
SCHEMBL14501332 0.78 CYP4F2 (0.63) CYP4F2CYP4A11ALDH1A1CYP3A4RECQL
SCHEMBL3179633 0.78 LCK (0.61) ALDH1A1CYP3A4RECQLKDM1AABL1
SCHEMBL31031626 0.78 LCK (0.61) ALDH1A1CYP3A4RECQLKDM1AABL1
SCHEMBL3179626 0.78 LCK (0.61) ALDH1A1CYP3A4RECQLKDM1AABL1
SCHEMBL9281030 0.78 ALDH1A1 (0.59) CYP4F2CYP4A11ALDH1A1CYP3A4RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040162331-A1 Pyrrole derivative DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2004-08-19 US disclosed
EP-1386913-A1 PYRROLE DERIVATIVE SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2004-02-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040162331-A1 Pyrrole derivative SLC5A1, GLP1R, SLC5A2 CYP4F2 2195/4885CYP4A11 1365/4885ALDH1A1 548/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.